|
FY2025
12 months to Oct 31, 2025
|
FY2024
12 months to Oct 31, 2024
|
FY2023
12 months to Oct 31, 2023
|
FY2022
12 months to Oct 31, 2022
|
FY2021
12 months to Oct 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Share-based compensation | |||||
| Depreciation and amortization | |||||
| Gain on extinguishment of finance obligations and debt, net | |||||
| Non-cash interest expense on finance obligations | |||||
| Unrealized (gain) loss on derivative contracts | |||||
| Operating lease costs | |||||
| Operating lease payments | |||||
| Impairment of property, plant and equipment and project assets | |||||
| Impairment expense | |||||
| Unrealized foreign currency losses | |||||
| Other, net | |||||
| Decrease (increase) in operating assets: | |||||
| Accounts receivable | |||||
| Unbilled receivables | |||||
| Inventories | |||||
| Other assets | |||||
| (Decrease) increase in operating liabilities: | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Project asset expenditures | |||||
| Maturity of held-to-maturity debt securities | |||||
| Purchases of held-to-maturity debt securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayment of debt and finance obligations | |||||
| Proceeds from the issuance of debt | |||||
| Payment for deferred financing costs | |||||
| Common stock issued for stock plans and related expenses | |||||
| Contributions received from sale of noncontrolling interest | |||||
| Distribution to noncontrolling interest | |||||
| Payments for taxes related to net share settlement of equity awards | |||||
| Common stock issuance, net of fees | |||||
| Payment of preferred dividends | |||||
| Net cash provided by financing activities | |||||
| Payment of deferred financing costs | |||||
| Proceeds from sale of common stock and warrant exercises, net of fees | |||||
| Effects on cash from changes in foreign currency rates | |||||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash-beginning of period | |||||
| Cash, cash equivalents and restricted cash-end of period | |||||
| Cash interest paid and early prepayment charge | |||||
| Accrued purchase of fixed assets, cash to be paid in subsequent period | |||||
| Accrued purchase of project assets, cash to be paid in subsequent period | |||||
Loading...